18 Oct 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Britain's Medicines and Healthcare products Regulatory Agency (MHRA) recalled five prescription-only drugs made by India's Wockhardt. The recalls were made after the MHRA found deficiencies in manufacturing procedures at the drugmaker's Chikalthana factory in India.
However, the agency said that there was no evidence that the products are defective. The MHRA also revealed that patients who already have the medicines do not need to return them. Pharmacies dispensing clinics and wholesalers have been asked to stop selling them.
MHRA said that its action follows a precautionary recall made by Wockhardt, which is asking retail outlets to return five over-the-counter medicines.